19 results on '"Ozaki, Toshifumi"'
Search Results
2. The current management of clear cell sarcoma
3. Advances in treatment of alveolar soft part sarcoma: an updated review.
4. Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†
5. Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
6. Current management of giant-cell tumor of bone in the denosumab era
7. Adjuvant and neoadjuvant chemotherapy for osteosarcoma: JCOG Bone and Soft Tissue Tumor Study Group
8. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304)
9. randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
10. Immunotherapy for sarcomas
11. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
12. Definitive radiation therapy in patients with unresectable desmoid tumors: a systematic review
13. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610
14. New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
15. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
16. Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†
17. New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
18. A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup
19. A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.